Complete nanoparticle characterisation, in-silicio predictive models for nano-risk assessment, invitro toxicology assessment, in-vivo models
To extend the test service portfolio, FlexFunction2Sustain establishes links with other EU initiatives and associations.
Our partners at the SAFE-N-MEDTECH OITB can provide comprehensive testing for safety and exposure risk assessment of nano-materials and devices functionalised with nanomaterials, specially on those cases related to medical devices.
SAFE-N-MEDTECH service portfolio includes:
- Complete nanoparticle characterisation.
- In-silico predictive models for nano-risk assessment.
- In-vitro toxicology assessment, including cellular uptake, cytotoxicity, and genotoxicity.
- In-vivo models.
For additional details, please, see SAFE-N-MEDTECH catalogue of services at https://safenmt.com
Deliverables
Specifications and Deliverables
– Complete nanoparticle characterisation.
– In-silico predictive models for nano-risk assessment.
– In-vitro toxicology assessment, including cellular uptake, cytotoxicity, and genotoxicity.
– In-vivo models.
– In-silico predictive models for nano-risk assessment.
– In-vitro toxicology assessment, including cellular uptake, cytotoxicity, and genotoxicity.
– In-vivo models.
Contact Listings Owner Form
Premium Members see more!
- Learn about who has visited this offer
- Get funding opportunities matching this technology
- Get detailed access statistics as listing owner